Literature DB >> 2441864

Phase II study of 5,6-dihydro-5-azacytidine in extensive, untreated non-small cell lung cancer.

P Y Holoye, H M Dhingra, T Umsawasdi, W K Murphy, D T Carr, J S Lee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2441864

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  1 in total

1.  Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesothelioma.

Authors:  H M Dhingra; W K Murphy; R J Winn; M N Raber; W K Hong
Journal:  Invest New Drugs       Date:  1991-02       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.